These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 12507537)
1. Antimuscarinics and the overactive detrusor--which is the main mechanism of action? Andersson KE; Yoshida M Eur Urol; 2003 Jan; 43(1):1-5. PubMed ID: 12507537 [TBL] [Abstract][Full Text] [Related]
2. Local effects of antimuscarinics. Masuda H; Kim YT; Tyagi S; Chancellor MB; de Miguel F; Yoshimura N Urol Clin North Am; 2006 Nov; 33(4):511-8, ix-x. PubMed ID: 17011387 [TBL] [Abstract][Full Text] [Related]
3. Muscarinic agonists and antagonists: effects on the urinary bladder. Sellers DJ; Chess-Williams R Handb Exp Pharmacol; 2012; (208):375-400. PubMed ID: 22222707 [TBL] [Abstract][Full Text] [Related]
4. Antimuscarinics and overactive bladder: other mechanism of action. Yamaguchi O Neurourol Urodyn; 2010; 29(1):112-5. PubMed ID: 19693952 [TBL] [Abstract][Full Text] [Related]
5. Antimuscarinic mechanisms and the overactive detrusor: an update. Andersson KE Eur Urol; 2011 Mar; 59(3):377-86. PubMed ID: 21168951 [TBL] [Abstract][Full Text] [Related]
6. The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: pathophysiology and pharmacotherapy of overactive bladder. Yoshida M; Masunaga K; Nagata T; Yono M; Homma Y J Pharmacol Sci; 2010; 112(2):128-34. PubMed ID: 20134115 [TBL] [Abstract][Full Text] [Related]
15. Muscarinic receptors in the bladder: from basic research to therapeutics. Hegde SS Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S80-7. PubMed ID: 16465186 [TBL] [Abstract][Full Text] [Related]
16. The role of muscarinic receptor subtypes on carbachol-induced contraction of normal human detrusor and overactive detrusor associated with benign prostatic hyperplasia. Yamanishi T; Kaga K; Fuse M; Shibata C; Kamai T; Uchiyama T J Pharmacol Sci; 2015 Jun; 128(2):65-70. PubMed ID: 26084660 [TBL] [Abstract][Full Text] [Related]
17. Overactive bladder inhibition in response to pelvic floor muscle exercises. Shafik A; Shafik IA World J Urol; 2003 May; 20(6):374-7. PubMed ID: 12682771 [TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of Overactive Bladder and Pharmacologic Treatments Including β3-Adrenoceptor Agonists -Basic Research Perspectives. Kwon J; Kim DY; Cho KJ; Hashimoto M; Matsuoka K; Kamijo T; Wang Z; Karnup S; Robertson AM; Tyagi P; Yoshimura N Int Neurourol J; 2024 Feb; 28(Suppl 1):12-33. PubMed ID: 38461853 [TBL] [Abstract][Full Text] [Related]
19. The inhibitory role of acetylcholine and muscarinic receptors in bladder afferent activity. Daly DM; Chess-Williams R; Chapple C; Grundy D Eur Urol; 2010 Jul; 58(1):22-8; discussion 31-2. PubMed ID: 20071074 [TBL] [Abstract][Full Text] [Related]
20. Antimuscarinic actions on bladder urothelium and lamina propria contractions are similar to those observed in detrusor smooth muscle preparations. Veer V; Chess-Williams R; Moro C Neurourol Urodyn; 2023 Jun; 42(5):1080-1087. PubMed ID: 36975140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]